RRC
46
-2
ZION
52
6
FSLR
64
-6
QRVO
56
4
OMC
62
14
UHS
58
4
HAS
52
3
CMG
53
-11
ES
60
5
CF
59
3
HBI
62
4
EBAY
50
-2
SLB
44
2
AN
50
7
ALLE
66
2
DAL
61
3
SE
65
4
AAL
50
-3
MLM
50
3
PSX
34
2
RRC
46
-2
ZION
52
6
FSLR
64
-6
QRVO
56
4
OMC
62
14
UHS
58
4
HAS
52
3
CMG
53
-11
ES
60
5
CF
59
3
HBI
62
4
EBAY
50
-2
SLB
44
2
AN
50
7
ALLE
66
2
DAL
61
3
SE
65
4
AAL
50
-3
MLM
50
3
PSX
34
2
Financhill
Back

Celldex Therapeutics Stock Predictions

Hope Is Not a Strategy!

Learn More
Buy
65

CLDX
Celldex Therapeutics

Last Price:
43.25
Seasonality Move:
-0.32%

7 Day Trial

ALL ACCESS PASS

$ 7

How Banks Can Seize Your Accounts

Learn More

Celldex Therapeutics Stock Forecast

  • Over the next 52 weeks, Celldex Therapeutics has on average historically risen by 33.4% based on the past 38 years of stock performance.
  • Celldex Therapeutics has risen higher in 15 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 39.47%
  • Is Celldex Therapeutics Stock Undervalued?
    The current Celldex Therapeutics [CLDX] share price is $44.16. The Score for CLDX is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • CLDX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Celldex Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Celldex Therapeutics has on average historically risen by 33.4% based on the past 38 years of stock performance.

Celldex Therapeutics Stock Rating

Buy
65
Celldex Therapeutics (CLDX) is a Buy

Is Celldex Therapeutics overpriced?

  • Celldex Therapeutics has risen higher in 15 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 39.47%

Celldex Therapeutics Stock Price History

Is CLDX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLDX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
celldex.com

52-Week Data

52-Week High:
53.18
52-Week Low:
22.11

Prediction Charts

Market Cap:
2.93B
Price in USD:
44.16
Volume:
542.93K
Beta:
1.80

Technical Analysis

SMA50:
38.02
SMA100:
37.55
SMA200:
38.47
52-Wk Change:
61.05%

Stock Predictions

  • Is Celldex Therapeutics stock public?
    Yes, Celldex Therapeutics is a publicly traded company.
  • What is the Celldex Therapeutics stock quote today?
    The Celldex Therapeutics stock price is 44.16 USD today.
  • How to buy Celldex Therapeutics stock online?
    You can buy Celldex Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-26 37.62 37.73 38.06 37.19
Aug-27 37.69 38.17 38.37 36.87
Aug-28 38.17 38.47 39.14 37.76
Aug-29 38.65 39.93 41.14 38.65
Aug-30 40.22 41.33 41.80 40.01
Sep-3 41.34 41.50 44.25 40.52
Sep-4 41.21 44.54 45.08 40.98
Sep-5 44.58 43.48 44.77 42.71
Sep-6 43.80 43.76 44.13 42.78
Sep-9 44.00 42.28 45.15 41.71
Sep-10 42.55 42.04 43.16 41.74
Sep-11 41.79 41.64 42.36 41.22
Sep-12 41.68 41.77 42.33 41.36
Sep-13 42.16 44.16 44.28 41.97

Celldex Therapeutics Earnings

Celldex Therapeutics Earnings Report: Per Share Celldex Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Celldex Therapeutics Forecast Revenue Growth

Celldex Therapeutics Stock Analysis: Historical quarterly revenues per share for Celldex Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.18 per share, an increase this year of $0.19 per share, and a decrease next year of $0.66 per share.

* Celldex Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.